Page last updated: 2024-08-24

ibandronic acid and Hemophilia B

ibandronic acid has been researched along with Hemophilia B in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adamidou, F; Anagnostis, P; Charizopoulou, M; Garipidou, V; Goulis, DG; Karagiannis, A; Karras, S; Vakalopoulou, S; Vyzantiadis, TA	1

Trials

1 trial(s) available for ibandronic acid and Hemophilia B

Article	Year
The effect of monthly ibandronate on bone mineral density and bone turnover markers in patients with haemophilia A and B and increased risk for fracture. Thrombosis and haemostasis, 2013, Volume: 110, Issue:2 Topics: Adult; Aged; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Remodeling; Diphosphonates; Drug Administration Schedule; Fractures, Bone; Hemophilia A; Hemophilia B; Humans; Ibandronic Acid; Male; Middle Aged; Osteoporosis; Prospective Studies; Risk Factors	2013

Article

Year

The effect of monthly ibandronate on bone mineral density and bone turnover markers in patients with haemophilia A and B and increased risk for fracture.

Thrombosis and haemostasis, 2013, Volume: 110, Issue:2

Topics: Adult; Aged; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Remodeling; Diphosphonates; Drug Administration Schedule; Fractures, Bone; Hemophilia A; Hemophilia B; Humans; Ibandronic Acid; Male; Middle Aged; Osteoporosis; Prospective Studies; Risk Factors

2013